European Heart Journal Review Time

For year-over-year citation metrics data, see the european heart journal citation metric page.

European Heart Journal was down from 39.7 in 2023 to 35.6 in 2024 after the pandemic-era cardiology citation peak continued to normalize. The practical implication is not a weaker journal. It is that EHJ has returned closer to its long-run flagship baseline while keeping the same editorial strictness on breadth.

The official European Heart Journal guidance explains the editorial workflow, but it does not publish one stable review-time number that authors should treat as a guarantee.

That means the honest way to read European Heart Journal timing is:

• expect a strong early editorial filter

• expect cardiovascular breadth and trial credibility to matter more than raw reviewer speed

• expect the total timeline to expand when the paper is promising but still borderline on flagship scope

That matters because European Heart Journal is not screening only for correct cardiology work. It is screening for studies that should matter across high-level cardiovascular practice.

The useful point is simple: European Heart Journal is efficient at telling you whether the paper belongs in the conversation, but the demanding part begins if it survives triage.

The slower papers are usually the ones that:

• are important cardiology studies but still too narrow for the ESC flagship

• look clinically relevant without enough broad practice consequence

• need deeper statistical or methodological scrutiny before the editors can commit

• return from revision with stronger data but unresolved breadth questions

That is why timing at European Heart Journal often reflects how convincingly the manuscript matters across cardiology practice, not just how quickly reviewers reply.

For EHJ-targeted manuscripts, three patterns most consistently predict slow review at European Heart Journal (European Society of Cardiology). Of manuscripts we screened in 2025 targeting EHJ and peer venues, the patterns below are the same ones our reviewers flag in real time. The named editorial-culture quirk: EHJ editors enforce practice-changing threshold with European-cardiology-practice relevance; preclinical-only papers without clinical-translation pathway get desk-rejected.

Scope-fit ambiguity in the abstract. EHJ editors move fastest on manuscripts whose contribution is obviously aligned with the journal's editorial scope (cardiovascular research with practice-changing implications for European-clinical-cardiology practice). The named failure pattern: preclinical-only cardiovascular papers without clinical-translation pathway get desk-rejected within 7-10 days. Check whether your abstract reads to EHJ's scope →

Methods package incomplete for the journal's reviewer pool. EHJ reviewers expect specific methodological detail. Trials missing pre-specified european-practice-relevance framing extend revision. Check if your methods package is reviewer-complete →

Reference-list and clean-citation failure mode. Editorial team at European Heart Journal (European Society of Cardiology) screens reference lists for retracted-paper inclusion. Check whether your reference list is clean against Crossref + Retraction Watch →

Editorial detail (for desk-screen calibration). Verify the current Editor-in-Chief and handling-editor list on the journal's editorial-team page before quoting any name in a submission cover letter. Submission portal: ScholarOne submission portal. Manuscript constraints: 350-word abstract limit and 5,000-word main-text cap (EHJ enforces during desk-screen).

We reviewed each of these constraints against current journal author guidelines (accessed 2026-05-08); evidence basis for the patterns above includes both publicly documented author-guidelines and our internal anonymized submission corpus.

Manusights submission-corpus signal for European Heart Journal (European Society of Cardiology). Of the manuscripts our team screened before submission to EHJ and peer venues in 2025, the editorial-culture mismatch most consistent across the cohort is EHJ editors enforce practice-changing threshold with european-cardiology-practice relevance; preclinical-only papers without clinical-translation pathway get desk-rejected.

In our analysis of anonymized EHJ-targeted submissions, the documented review timeline shows a bimodal distribution between manuscripts that clear EHJ's scope-fit threshold within the first week and those that get extended editorial-board consultation. Top-line triage is handled by the journal's editorial team; verify the current handling editor on the journal's editorial-team page before quoting any name in a cover letter.

Fast rejection does not mean the science is weak. It often means the editors do not think the manuscript clears the flagship cardiology bar for European Heart Journal specifically.

A longer review path does not mean acceptance is likely either. It often means the paper had enough promise to justify a harder test.

So timing is best read here as a scope-fit signal, not just a speed signal.

The better question is whether the manuscript is truly an European Heart Journal paper.

That is why the better next reads are:

• European Heart Journal selectivity context

• European Heart Journal SJR and Scopus metrics

• European Heart Journal submission guide

• European Heart Journal submission process

If the paper has broad cardiovascular consequence, the slower and harder timeline may be worth it. If the story is strong but narrower, the same timeline becomes a reason to choose a different cardiology journal first.

European Heart Journal is not the journal to choose because you want a neat fast review clock. It is the journal to choose when the manuscript genuinely deserves ESC flagship attention.

So the useful takeaway is not one exact week count. It is this: expect fast triage, expect a tougher review path if the paper survives, and decide based on cardiovascular consequence rather than wishful thinking about speed. A European Heart Journal submission framing check is a direct way to pressure-test that before submission.

The review process at European Heart Journal follows a standard sequence, but the timing at each stage varies:

• Desk decision (1-3 weeks): The editor evaluates scope fit, novelty, and basic quality. This is the highest-risk point - many papers are rejected here without external review.

• Reviewer assignment (1-2 weeks): Finding qualified, available reviewers is often the biggest source of delay. Niche topics take longer.

• First reviewer reports (3-6 weeks): Reviewers typically have 2-3 weeks to respond, but many request extensions. Two reports is standard; three is common for interdisciplinary work (per SciRev community data and JCR latest release).

• Editorial decision (1-2 weeks): The editor synthesizes reports and decides: accept, minor revision, major revision, or reject.

If your status hasn't changed in several weeks, the most common explanations are:

• Still "under review" after 6+ weeks: Likely waiting on a slow reviewer. Editors typically send reminders at 3-4 weeks.

• "Decision pending" for 2+ weeks: The editor may be waiting for a third reviewer, or handling a split decision between reviewers.

• Back to "under review" after revision: Revised manuscripts usually go back to the original reviewers, who may take 2-4 weeks.

A polite status inquiry is appropriate after 8 weeks with no update.

For career-critical deadlines (grant applications, job market cycles, tenure review):

• Submit at least 6 months before your hard deadline

• Have a backup journal identified before you submit

• If the timeline matters more than the venue, consider journals with faster review (check our review time comparison pages)

The Manusights EHJ readiness scan. This guide tells you what European Heart Journal (European Society of Cardiology)'s editors look for in the first 1-2 weeks of triage. The review tells you whether your paper passes that check before you submit.

We have reviewed manuscripts targeting European Heart Journal (European Society of Cardiology) and peer venues; the named patterns below are the same ones the journal's handling editors and outside reviewers flag at the desk-screen and first-review stages. documented review timeline of approximately 7-10 days for desk-screen. 60-day money-back guarantee. We do not train AI on your manuscript and delete it within 24 hours.

Published timelines are medians that mask real variation. Desk rejections skew the median down. Seasonal effects and field-specific reviewer availability affect your specific wait.

A European Heart Journal desk-rejection risk check scores fit against the journal's editorial bar.